Continental Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-9,902
Closed -$1.03M 82
2020
Q3
$1.03M Hold
9,902
0.55% 60
2020
Q2
$908K Hold
9,902
0.49% 59
2020
Q1
$893K Buy
+9,902
New +$1.05M 0.66% 57
2015
Q1
Sell
-29,995
Closed -$2.17M 160
2014
Q4
$2.17M Sell
29,995
-61,460
-67% -$4.27M 0.44% 73
2014
Q3
$5.67M Buy
91,455
+27,000
+42% +$1.72M 1.29% 15
2014
Q2
$4.11M Buy
64,455
+500
+0.8% +$30.4K 0.96% 30
2014
Q1
$3.94M Sell
63,955
-2,000
-3% -$116K 1.02% 28
2013
Q4
$3.79M Hold
65,955
0.82% 29
2013
Q3
$3.51M Hold
65,955
0.87% 28
2013
Q2
$3.4M Buy
+65,955
New +$3.26M 0.96% 29

Other funds holding MDT

Continental Advisors's MDT Position: Q4 2020 in Review

Continental Advisors sold out of Medtronic (MDT) in Q4 2020, closing a stake of 9,902 shares — an estimated $1.03M sold.

Continental Advisors first reported a position in MDT in Q2 2013 and held it in 10 quarters. The position peaked at $5.67M in Q3 2014. 1,957 funds tracked by Wall St. Rank hold MDT as of Q4 2020.

  • Continental Advisors reported no remaining Medtronic position as of Q4 2020 after selling out during the quarter.
  • Continental Advisors sold 9,902 Medtronic shares in Q4 2020, an estimated $1.03M.
  • Continental Advisors first reported a position in Medtronic in Q2 2013 and held it in 10 quarters.
  • Continental Advisors's Medtronic position peaked at $5.67M in Q3 2014.
  • 1,957 funds tracked by Wall St. Rank held Medtronic as of Q4 2020.

Based on Continental Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.